{
    "SPADE_N_00175": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_00175",
            "Peptide Name": "Lactocin S (Bacteriocin)",
            "Source": "Lactobacillus sakei L45 (Gram-positive bacteria)",
            "Family": "Not found",
            "Gene": "lasA",
            "Sequence": "STPVLASVAVSMELLPTASVLYSDVAGCFKYSAKHHC",
            "Sequence Length": 37,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P23826",
                "http://www.uniprot.org/uniprot/Q48848",
                "http://www.uniprot.org/uniprot/Q48858"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial"
            ],
            "Target Organism": "Leuconostoc, Carnobacteria, Lactobacilli, Pediococci, Lactococci, Listeria monocytogenes, Listeria innocua, Staphylococcus, Bacillus cereus, Clostridium spp.",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Cell membrane",
            "Linear/Cyclic": "Cyclic",
            "N-terminal Modification": "Deaminated",
            "C-terminal Modification": "Cyclization  between S32 and C37",
            "Stereochemistry": "Mixed(D-Ala)",
            "Structure Description": "Not found",
            "Formula": "C173H273N43O52S3",
            "Mass": 3883.47,
            "PI": 6.66,
            "Net Charge": 2,
            "Hydrophobicity": 0.58,
            "Half Life": "Mammalian:1.9 hourYeast:>20 hourE.coli:>10 hour",
            "Mechanism of action": "The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.",
            "PTM": "Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor.",
            "Literature": [
                {
                    "Title": "Purification and amino acid sequence of lactocin S, a bacteriocin produced by Lactobacillus sake L45.",
                    "Pubmed ID": "1872611",
                    "Reference": "Appl Environ Microbiol. 1991 Jun;57(6)1829-1834.",
                    "Author": "MÂ¸rtvedt CI, Nissen-Meyer J, Sletten K, Nes IF.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=1872611"
                },
                {
                    "Title": "In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide.",
                    "Pubmed ID": "7961627",
                    "Reference": "J Biol Chem. 1994 Nov 4;269(44)27183-27185.",
                    "Author": "Skaugen M, Nissen-Meyer J, Jung G, Stevanovic S, Sletten K, Inger C, Abildgaard M, Nes IF.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=7961627"
                }
            ],
            "Frequent Amino Acids": "SAV",
            "Absent Amino Acids": "INOQRUW",
            "Basic Residues": 4,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 20,
            "Polar Residues": 26,
            "Positive Residues": 4,
            "Negative Residues": 2,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_06091",
                    "Similarity": 1.0,
                    "Sequence": "MKTEKKVLDELSLHASAKMGARDVESSMNADSTPVLASVAVSMELLPTASVLYSDVAGCFKYSAKHHC"
                }
            ]
        }
    }
}